Buyer beware: Off-brand Ozempic, Zepbound and other weight loss products carry undisclosed risks for consumers
- Written by C. Michael White, Distinguished Professor of Pharmacy Practice, University of Connecticut
In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to control blood sugar levels and reduce the risk of heart disease.
But the price of these injections is steep: They cost about US$800-$1,000 per month, and if used for...










